MedTrace Logo

Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany

NCT07002047 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81239

Last updated 2026-05-04

No results posted yet for this study

Summary

This study assesses the epidemiologic situation of chlamydia trachomatis, its complications and long term sequalae and related healthcare resource utilization and costs among adults in Germany.

The study is a retrospective cohort study based on German Statutory Health Insurance (SHI) claims data for adolescents and adults aged 14 to 44 years in the years 2008-2022 with documented (confirmed) diagnosis of CT.

Study Objectives are to:

1. Estimate frequency of potential short-term complications and long-term sequelae in patients with medically attended chlamydia infection
2. Analyze time from first documented prevalent CT infection to first potential complication/sequelae diagnosis
3. Estimate frequency of re-infection (chlamydia recurrence) and co-infections with other sexually transmitted infections (STIs) in patients with medically-attended chlamydia infection
4. Estimate absolute healthcare resource utilization (by level of care and specialty) and costs in patients with chlamydia infection, including for potential short-term complications and long-term sequelae
5. Estimate administrative prevalence of medically-attended chlamydia infection in the overall study population
6. Estimate administrative prevalence of diagnoses potentially associated with a chlamydia infection (i.e., short-term complications/long-term sequelae) in the overall study population
7. Estimate frequency of chlamydia testing in the overall study population

Conditions

  • Chlamydia Trachomatis

Sponsors & Collaborators

Eligibility

Min Age
14 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-13
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07002047 on ClinicalTrials.gov